Welltower Inc. (NYSE:WELL – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fifteen research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation, ten have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $225.4286.
Several equities research analysts recently weighed in on WELL shares. Wall Street Zen downgraded shares of Welltower from a “hold” rating to a “sell” rating in a report on Saturday, February 14th. Jefferies Financial Group reissued a “buy” rating and set a $231.00 target price on shares of Welltower in a research note on Monday, December 15th. Cantor Fitzgerald boosted their price target on shares of Welltower from $204.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, February 12th. Morgan Stanley upped their price target on shares of Welltower from $200.00 to $215.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 18th. Finally, Mizuho increased their price objective on shares of Welltower from $216.00 to $231.00 and gave the company an “outperform” rating in a report on Wednesday, March 4th.
View Our Latest Research Report on Welltower
Hedge Funds Weigh In On Welltower
Welltower Trading Down 0.0%
Shares of WELL stock opened at $195.75 on Friday. Welltower has a 1 year low of $130.29 and a 1 year high of $216.43. The firm has a market capitalization of $136.59 billion, a PE ratio of 139.83, a price-to-earnings-growth ratio of 1.34 and a beta of 0.82. The stock has a fifty day moving average of $200.09 and a two-hundred day moving average of $190.00. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 3.46.
Welltower (NYSE:WELL – Get Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The real estate investment trust reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.44 by $0.01. Welltower had a return on equity of 2.46% and a net margin of 8.64%.The company had revenue of $3.18 billion for the quarter, compared to analyst estimates of $2.93 billion. During the same period last year, the company earned $1.13 earnings per share. The company’s quarterly revenue was up 41.3% compared to the same quarter last year. Welltower has set its FY 2026 guidance at 6.090-6.25 EPS. As a group, research analysts expect that Welltower will post 4.88 EPS for the current year.
Welltower Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 10th. Shareholders of record on Wednesday, February 25th were given a $0.74 dividend. This represents a $2.96 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date was Wednesday, February 25th. Welltower’s dividend payout ratio is 211.43%.
Welltower Company Profile
Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.
The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.
See Also
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.
